Leading research in biotechnology, MIB TH is developing a new bioproduct and extending its production capacity through the EEA and Norway Grants
The city of Iasi, NE Romania, hosts a regional leader in biotechnology in the the fields of Antibitoics, Active Pharma Ingredients, Aminoacids, Vitamins, both for human and animal use. The company is called M.I.B. T.H (Man Tobias Biotechnology) and have delivered more than 20 different industrialized technology processes to markets like China, India, Europe and USA.
Their latest project focuses on the development of new bioproduct (A-Gluten) for food and healthcare sector, all the while investing heavily for the purposes of increasing the company's production capacity through the EEA and Norway Grants.
International Development Norway is joining MIB TH to provide expertise in the process of designing the automation and digitalization plan for the production processes related to current operations. The partner will contribute with valuable insights into the introduction of a new waste management and a new energy management plan. The piloting of a specific Smart Factory model will also be among the tasks of the Norwegian partner.
IDN Norway is a spin-out from the SINTEF foundation, the largest contract research institute in Scandinavia. Within industry IDN Norway is focused on renewable energy, environmental technology, industrial production and ICT.
Watch CEO Elena Nechita's testimonial below.
CEO Elena Nechita: "Innovation Norway is a flexible, results-oriented funding partner and we highly recommend applying for funding under their dedicated programs"
The project is supported by Norway, Iceland and Liechtenstein through the EEA and Norway Grants. See more opportunities under the SMEs Growth Programme.
Follow the EEA and Norway Grants by Innovation Norway on Facebook or on LinkedIn to stay updated.
